CD4-directed peptide vaccination augments an antitumor response, but efficacy is limited by the number of CD8+ T cell precursors (Q40575848)

From Wikidata
Jump to navigation Jump to search
scientific article published on April 2004
edit
Language Label Description Also known as
English
CD4-directed peptide vaccination augments an antitumor response, but efficacy is limited by the number of CD8+ T cell precursors
scientific article published on April 2004

    Statements

    CD4-directed peptide vaccination augments an antitumor response, but efficacy is limited by the number of CD8+ T cell precursors (English)
    Holly L Hanson
    Silvia S Kang
    Lyse A Norian
    Ken Matsui
    Leigh A O'Mara
    Paul M Allen
    1 April 2004
    4215-4224

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit